Benzinga''s Top Ratings Upgrades, Downgrades For June 8, 2022
Upgrades For Crescent Point Energy Corp (NYSE: CPG ), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. In the first quarter, Crescent Point Energy showed an EPS of $0.32, compared to $0.14 from the year-ago quarter. The current stock performance of Crescent Point Energy shows a 52-week-high of $10.42 and a 52-week-low of $2.75. Moreover, at the end of the last trading period, the closing price was at $10.40. For Enerplus Corp (NYSE: ERF ), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. For the first quarter, Enerplus had an EPS of $0.58, compared to year-ago quarter EPS of $0.18. The current stock performance of Enerplus shows a 52-week-high of $17.68 and a 52-week-low of $4.78. Moreover, at the end of the last trading period, the closing price was at $17.51. B of A Securities upgraded the previous rating for Radius Health Inc (NASDAQ: RDUS ) from Underperform to Neutral. In the first quarter, Radius Health showed an EPS of $0.39, compared to $0.18 from the year-ago quarter.
Benzinga''s Top Ratings Upgrades, Downgrades For June 8, 2022
Upgrades For Crescent Point Energy Corp (NYSE: CPG ), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. In the first quarter, Crescent Point Energy showed an EPS of $0.32, compared to $0.14 from the year-ago quarter. The current stock performance of Crescent Point Energy shows a 52-week-high of $10.42 and a 52-week-low of $2.75. Moreover, at the end of the last trading period, the closing price was at $10.40. For Enerplus Corp (NYSE: ERF ), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. For the first quarter, Enerplus had an EPS of $0.58, compared to year-ago quarter EPS of $0.18. The current stock performance of Enerplus shows a 52-week-high of $17.68 and a 52-week-low of $4.78. Moreover, at the end of the last trading period, the closing price was at $17.51. B of A Securities upgraded the previous rating for Radius Health Inc (NASDAQ: RDUS ) from Underperform to Neutral. In the first quarter, Radius Health showed an EPS of $0.39, compared to $0.18 from the year-ago quarter.